Effect of azilsartan versus candesartan on morning blood pressure surges in Japanese patients with essential hypertension

Blood Pressure Monitoring

Volumn 19, Issue 3, 2014, Pages 164-169

  Rakugi, Hiromi ^a   Kario, Kazuomi ^c   Enya, Kazuaki ^b   Sugiura, Kenkichi ^b   Ikeda, Yoshinori ^b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

azilsartan; candesartan; hypertension; morning blood pressure surge

Indexed keywords

AZILSARTAN; CANDESARTAN; ANTIHYPERTENSIVE AGENT; BENZIMIDAZOLE DERIVATIVE; OXADIAZOLE DERIVATIVE; TETRAZOLE DERIVATIVE;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; DRUG EFFICACY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORNING BLOOD PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTOLIC BLOOD PRESSURE; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; HYPERTENSION; JAPAN; MULTICENTER STUDY; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL;

AGED; ANTIHYPERTENSIVE AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; BENZIMIDAZOLES; BLOOD PRESSURE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERTENSION; JAPAN; MALE; MIDDLE AGED; OXADIAZOLES; TETRAZOLES;

EID: 84900403370     PISSN: 13595237     EISSN: 14735725     Source Type: Journal    
DOI: 10.1097/MBP.0000000000000042     Document Type: Article

References (34)

1. Willich SN, Levy D, Rocco MB, Tofler GH, Stone PH, Muller JE. Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population. Am J Cardiol 1987; 60:801-806.
2. Muller JE, Stone PH, Turi ZG, Rutherford JD, Czeisler CA, Parker C, et al. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 1985; 313:1315-1322.
3. Muller JE, Ludmer PL, Willich SN, Tofler GH, Aylmer G, Klangos I, et al. Circadian variation in the frequency of sudden cardiac death. Circulation 1987; 75:131-138.
4. Maron BJ, Kogan J, Proschan MA, Hecht GM, Roberts WC. Circadian variability in the occurrence of sudden cardiac death in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1994; 23:1405-1409.
5. Willich SN, Goldberg RJ, Maclure M, Perriello L, Muller JE. Increased onset of sudden cardiac death in the first three hours after awakening. Am J Cardiol 1992; 70:65-68.
6. Muller JE, Tofler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation 1989; 79:733-743.
7. Asayama K, Ohkubo T, Kikuya M, Obara T, Metoki H, Inoue R, et al. Prediction of stroke by home 'morning' versus 'evening' blood pressure values: the Ohasama study. Hypertension 2006; 48:737-743.
8. Miura K, Nakagawa H, Tabata M, Morikawa Y, Nishijo M, Kagamimori S. Birth weight, childhood growth, and cardiovascular disease risk factors in Japanese aged 20 years. Am J Epidemiol 2001; 153:783-789.
9. Kario K. Time for focus on morning hypertension: pitfall of current antihypertensive medication. Am J Hypertens 2005; 18:149-151.
10. Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation 2003; 107:1401-1406.
11. Gosse P, Lasserre R, Minifie C, Lemetayer P, Clementy J. Blood pressure surge on rising. J Hypertens 2004; 22:1113-1118.
12. Metoki H, Ohkubo T, Kikuya M, Asayama K, Obara T, Hashimoto J, et al. Prognostic significance for stroke of a morning pressor surge and a nocturnal blood pressure decline: the Ohasama study. Hypertension 2006; 47:149-154.
13. Kuwajima I, Mitani K, Miyao M, Suzuki Y, Kuramoto K, Ozawa T. Cardiac implications of the morning surge in blood pressure in elderly hypertensive patients: relation to arising time. Am J Hypertens 1995; 8:29-33.
14. Kario K, Pickering TG, Hoshide S, Eguchi K, Ishikawa J, Morinari M, et al. Morning blood pressure surge and hypertensive cerebrovascular disease: role of the alpha adrenergic sympathetic nervous system. Am J Hypertens 2004; 17:668-675.
15. Kaneda R, Kario K, Hoshide S, Umeda Y, Hoshide Y, Shimada K. Morning blood pressure hyper-reactivity is an independent predictor for hypertensive cardiac hypertrophy in a community-dwelling population. Am J Hypertens 2005; 18:1528-1533.
16. Polónia J, Amado P, Barbosa L, Nazaré J, Silva JA, Bertoquini S, et al. Morning rise, morning surge and daytime variability of blood pressure and cardiovascular target organ damage. A cross-sectional study in 743 subjects. Rev Port Cardiol 2005; 24:65-78.
17. Zakopoulos NA, Tsivgoulis G, Barlas G, Papamichael C, Spengos K, Manios E, et al. Time rate of blood pressure variation is associated with increased common carotid artery intima-media thickness. Hypertension 2005; 45:505-512.
18. Marfella R, Siniscalchi M, Portoghese M, Di Filippo C, Ferraraccio F, Schiattarella C, et al. Morning blood pressure surge as a destabilizing factor of atherosclerotic plaque: role of ubiquitin-proteasome activity. Hypertension 2007; 49:784-791.
19. Kario K. Vascular damage in exaggerated morning surge in blood pressure. Hypertension 2007; 49:771-772.
20. Li Y, Thijs L, Hansen TW, Kikuya M, Boggia J, Richart T, et al. Prognostic value of the morning blood pressure surge in 5645 subjects from 8 populations. Hypertension 2010; 55:1040-1048.
21. Kario K, Ishikawa J, Pickering TG, Hoshide S, Eguchi K, Morinari M, et al. Morning hypertension: the strongest independent risk factor for stroke in elderly hypertensive patients. Hypertens Res 2006; 29:581-587.
22. Ojima M, Igata H, Tanaka M, Sakamoto H, Kuroita T, Kohara Y, et al. In vitro antagonistic properties of a new angiotensin type 1 receptor blocker, azilsartan, in receptor binding and function studies. J Pharmacol Exp Ther 2011; 336:801-808.
23. Rakugi H, Enya K, Sugiura K, Ikeda Y. Comparison of the efficacy and safety of azilsartan with that of candesartan cilexetil in Japanese patients with grade I-II essential hypertension: a randomized, double-blind clinical study. Hypertens Res 2012; 35:552-558.
24. Rakugi H, Kario K, Enya K, Igeta M, Ikeda Y. Effect of azilsartan versus candesartan on nocturnal blood pressure variation in Japanese patients with essential hypertension. Blood Press 2013; 22 (Suppl 1):22-28.
25. Eguchi K, Kario K, Hoshide Y, Hoshide S, Ishikawa J, Morinari M, et al. Comparison of valsartan and amlodipine on ambulatory and morning blood pressure in hypertensive patients. Am J Hypertens 2004; 17:112-117.
26. Eguchi K, Kario K, Shimada K. Comparison of candesartan with lisinopril on ambulatory blood pressure and morning surge in patients with systemic hypertension. Am J Cardiol 2003; 92:621-624.
27. Kumagai Y. Strategies against high blood pressure in the early morning. Clin Exp Hypertens 2004; 26:107-118.
28. Kario K. Preceding linkage between a morning surge in blood pressure and small artery remodeling: an indicator of prehypertension? J Hypertens 2007; 25:1573-1575.
29. Yano Y, Hoshide S, Inokuchi T, Kanemaru Y, Shimada K, Kario K. Association between morning blood pressure surge and cardiovascular remodeling in treated elderly hypertensive subjects. Am J Hypertens 2009; 22: 1177-1182.
30. Kario K. Morning surge in blood pressure and cardiovascular risk: evidence and perspectives. Hypertension 2010; 56:765-773.
31. Arakawa K, Shimamoto K, Abe K, Saruta T, Ishii M, Ogihara T, et al. Parallelgroup controlled clinical study on CS-866 (olmesartan medoxomil), a novel angiotensin II AT1 receptor antagonist, compared with enalapril maleate in patients with mild-to-moderate essential hypertension [in Japanese]. J Clin Ther Med 2004; 20:115-159.
32. Arakawa K, Ogihara T, Iimura O, Abe K, Saruta T, Ishii M, et al. Evaluation of clinical usefulness of TCV-116 (candesartan cilexetil) in patients with essential hypertension: a double-blind, parallel-group comparison study using enalapril maleate as control drug [in Japanese]. J Clin Ther Med 1998; 14:871-918.
33. Yoshinaga K, Iimura O, Abe K, Saruta T, Arakawa M, Yazaki Y, et al. Clinical evaluation of CGP 48933 (valsartan) monotherapy in essential hypertension: double-blind comparative study with enalapril maleate [in Japanese]. J Clin Ther Med 1998; 14:2355-2404.
34. Arakawa K, Abe K, Saruta T, Yazaki Y, Ishii M, Ogihara T, et al. A double-blind comparison of efficacy and safety of BIBR277 (telmisartan), the long-acting angiotensin II AT1 receptor antagonist, and enalapril maleate in patients with mild-to-moderate essential hypertension: a multicenter, randomized, parallel-group comparison study [in Japanese]. Jpn Pharmacol Ther 2002; 30:639-660.